The functional fitness Method launches a new movement category, a scientist-formulated recovery product, an expert Clinical Advisory Board and vows to get 30 million women moving functionally by 2030
New York, New York –News Direct– P.volve
P.volve, the functional fitness brand revolutionizing the way women move, live and feel, announced today a transformative rebrand to bridge the gap between fitness, women’s health and physical therapy. With this new company-wide direction, P.volve will unveil a whole new look and feel to their online and brick-and-mortar presence by gracefully connecting movement to the essence of nature through neutral colors and textures reflective of our environment. Additionally, the brand will introduce a new, life changing category of fitness called ‘Movement Therapy’; announce their expert Clinical Advisory Board, launch their first-ever ingestible recovery solution and more. With these monumental enhancements to the brand’s vision, purpose and mission, P.volve is for women to sculpt their body, support long-term health and restore vitality by delivering powerful, steadfast results.
P.volve, which derives from the phrase ‘Personal Evolution’ is doing just that – helping millions of women evolve with their body through every stage of life, building the most powerful version of themselves with a workout to strengthen, sustain and recover. Focusing on ‘Natural Connection’, this new brand direction celebrates and honors the beautiful fluidity of nature and the human body, shown throughout every aspect of the rebrand.
“We are thrilled to reintroduce P.volve as a Method that is disrupting the way we look at movement and teaching women all over the world to expect more from their fitness,” says Co-Founder, Rachel Katzman. “So many women, myself included, have been let down by traditional fitness, left not meeting goals and broken down. With this movement you can exceed all your goals – the butt you always wanted, mitigate everyday pain, balance your hormones and overall feel the best you’ve ever felt in your body. I speak with members of all ages every single week and continue to be inspired and motivated by the stories they share about how P.volve has helped strengthen, nourish and restore their bodies throughout their lives. Our method, our experience, our equipment, and now our first-ever recovery supplement are all designed to evolve with a woman’s body over time so she can feel the life changing power of daily, functional movement.”
With the goal of opening 250 brick-and-mortar studios by 2025 and getting 30 million women to move functionally by 2030, P.volve will be rolling out the following initiatives to create a comprehensive, best-in-class and cutting-edge experience for their members and beyond:
Bridging the Gap Between Healthcare and Fitness:
Building a World-Class Clinical Advisory Board – P.volve’s Clinical Advisory Board (CAB), made up of seasoned medical doctors and experts, including Dr. Amy Hoover, Dr. Nima Alamdari, and Dr. Suman Tewari collaborate to create workouts, advise on equipment and develop new products. Together, they are helping us to ensure that the P.volve Method is rooted in science and research. Currently P.volve's trusted team of experts are going through multiple clinical trials, including three with the University of Exeter in the UK, a top 10 globally ranked university in sports related subjects. The studies will focus on muscle recovery strategies as well as the impact of the method on young and older adults; slated for completion in 2025. Most recently, preliminary results in a University of Minnesota clinical study of adults with chronic lower back pain showed that 12 weeks of the P.volve Back Strengthening Series workout (whole body low-intensity exercises that focus on the pelvic floor and strengthening the core): significantly reduced pain, improved body awareness and strength and reduced fearful avoidance of movement. Lower back pain is an ailment that up to 80% of Americans will develop in their lifetime, with up to 15-20% of adults reporting it in an average year.
‘Prescribing P.volve’ Pilot Program – While P.volve is not a medical treatment that requires a prescription, Dr. Amy Hoover, Founding P.volve CAB member and Resident Physical Therapist specializing in pelvic health, is spearheading a pilot program with a network of doctors throughout the U.S. whereby they recommend P.volve’s Movement Therapy programming to patients as part of their continuous care treatment plan. “Many people are failed by the healthcare system when it comes to fitness, movement and exercise. They are told to exercise, but then not guided on what works best for their specific body. I love this method because it not only helps to restore proper muscle balance and biomechanics, but also teaches people about how their body works. P.volve connects them to their own body and helps them identify their own specific needs, which empowers them to help restore themselves through movement. I use this method to complement treatments for my patients,” says Dr. Hoover.
Partnerships in Healthcare – As part of its mission to help 30 million women move better and live better by 2030, P.volve is partnering with top healthcare brands such as Ovia Health, Spring Fertility, Medicare Fitness Programs, Amazon Halo, Integrative Institute for Nutrition and Sugarbreak. Together, they are providing holistic solutions and resources for women, while making the P.volve Method more accessible to those who need it most.
Introducing a New Category of Fitness: As part of the mission to elevate what women can expect from their fitness routine, P.volve launched Movement Therapy, a new category of workouts developed by expert Trainers in collaboration with the Clinical Board. These programs deliver strong, balanced and resilient physiques, while also addressing the pain points and sensitivities that patients and members commonly experience. This includes female-specific need-states, such as pelvic floor health, managing symptoms related to menstrual cycle, workouts for pre and post natal, and managing with endometriosis. It also addresses everyday aches and pains related to knees, hips, back, wrists and more.
Accelerating Recovery: P.volve believes that daily, functional movement is necessary for a woman to live a healthy and sustainable life. Understanding that muscle recovery is a critical component to the ability to move daily with ease, P.volve is launching a great-tasting, easy to use, and scientifically-backed powdered recovery solution, Recover 9, to enable members to recover faster and experience less muscle soreness. The formulation was developed in partnership with scientists and includes all nine essential amino acids and pomegranate fruit extract. This first-of-its-kind blend is sourced from best-in-class ingredients and manufacturers, is vegan, sugar-free, non-GMO, contains no artificial flavors, and is free of gluten and all major allergens. Recover 9 joins P.volve’s pre-existing proprietary product line up, including the p.ball, p.band, and p.3 trainer.
Member Advisory Board: With a strong legacy of using member feedback to drive key business decisions, P.volve appointed an official Member Advisory Board comprised of brand advocates globally. The Board meets virtually every month and uses WhatsApp daily to communicate and share feedback with P.volve Leadership. The Board is charged with bringing the voice of the member to the team so that member feedback is consistently represented and prioritized across the business.
With a belief that women have been underserved by traditional fitness modalities, P.volve is raising the bar within industry and teaching women all around the globe to expect more from their fitness – because any fitness can deliver toned physiques, but the ability to both strengthen and restore the body is the future. With an expert Clinical Team, University-led Clinical Trials, a growing list of partners within the healthcare space and a new category of Movement Therapy, this is just the beginning for P.volve.
ABOUT P.VOLVE
P.volve is a leading science-backed, holistic fitness Method for women that harnesses the power of functional movement to nourish and heal while it shapes, tones, and strengthens. The Method supports women’s evolving needs and empowers its members to move with ease—for life. Experienced in-studio and virtually, P.volve offers a growing franchise studio footprint, proprietary equipment, an on-demand and live-streaming platform, and a recovery supplement. P.volve launched in November 2017 and was co-founded by Rachel Katzman, in partnership with Camelot Venture Group, whose portfolio companies include 1-800 CONTACTS, SmileDirectClub and Quicken Loans. Available worldwide, P.volve is headquartered in New York City. For more information, please visit www.pvolve.com and @pvolve on Instagram.
Courtney Stewart
[email protected]
https://www.pvolve.com
View source version on newsdirect.com: https://newsdirect.com/news/functional-fitness-brand-p-volve-announces-transformative-rebrand-to-revolutionize-the-fitness-and-womens-wellness-industries-582787113
American depositary shares of Chinese electric vehicle (EV) maker Nio (NYSE: NIO) have fallen sharply so far in 2022. Nio is getting hit hard again Monday as U.S.-listed Chinese companies are looking more at risk of being delisted. Last week, five Chinese companies were specifically named as being in danger of meeting that criterion, meaning they could be delisted in 2024 if they fail to comply.
Shares of the buy now, pay later (BNPL) company Affirm Holdings (NASDAQ: AFRM) fell more than 15% today after the company raised its guidance but also had to reportedly halt a bond sale last week. For the third quarter, Affirm essentially just said that it plans to at least hit the top end of the guidance it previously provided on Feb. 10. Management now expects Affirm to see third-quarter gross merchandise volume (GMV) of at least $3.71 billion, revenue of at least $335 million, and revenue less transactions costs of at least $148 million, which is $5 million more than the top end of its previous guidance.
Bloomberg Intelligence's Mike McGlone joins Yahoo Finance Live to discuss the oil market as the Russia-Ukraine war continues and the outlook for metals amid supply concerns.
On Monday, three days before GameStop (NYSE: GME) is scheduled to unveil its latest set of quarterly results, a rather bearish research note on the company prompted investors to sell out of the company. On Monday, Pachter wrote a client note reiterating his underweight (read: sell) recommendation on GameStop stock at a price target of $45 per share (the company currently trades at just over $78). In his view, it could see "modest" revenue growth this year and even has a shot at landing in the black on the bottom line.
Fears about investing in Chinese tech stocks reached a fever pitch Monday, as international megabank J.P. Morgan announced "double-downgrades" on three of the biggest names in China tech: Baidu (NASDAQ: BIDU), NetEase (NASDAQ: NTES), and Alibaba Group Holding Limited (NYSE: BABA). As of noon ET, NetEase shares are down 7.2% from Friday's close, Baidu stock is off 7.5%, and Alibaba is leading the Chinese tech sector lower with a loss of 8.2%. For one thing, there's the continuing risk that a whole lot of Chinese stocks — even the big ones — might have to delist from U.S. stock exchanges if China's government can't find a way to work with their U.S. counterparts to permit full and accurate auditing of Chinese companies' financial reports.
(Bloomberg) — Chinese stocks listed in Hong Kong had their worst day since the global financial crisis, as concerns over Beijing’s close relationship with Russia and renewed regulatory risks sparked panic selling.Most Read from BloombergElon Musk Challenges Vladimir Putin to ‘Single Combat’ for UkraineUkraine Update: New Round of Talks; U.S-China Officials to MeetPregnant Woman Pictured Being Evacuated From Bombed Maternity Ward Has DiedPanic Selling Grips Chinese Stocks in Biggest Plunge Since
Uranium Energy (NYSEMKT: UEC) stock cracked on Monday and sank as much as 13.2% as of 12:20 p.m. ET. Today's drop brings the red-hot uranium stock's unstoppable rally to a grinding halt — Uranium Energy shares had jumped a whopping 90% since Feb. 1 through the end of last week. In fact, uranium spot prices have hit their highest level since March 2011 and are hovering around $60 per pound, according to TradingEconomics.com.
What happened Shares of several COVID-19 vaccine companies were jumping as of 11:43 a.m. ET on Monday. BioNTech (NASDAQ: BNTX) was the biggest mover, with its shares soaring 14.7%. Dynavax Technologies (NASDAQ: DVAX) was vaulting 5.
The share prices of Shopify (NYSE: SHOP), Doximity (NYSE: DOCS), and Datadog (NASDAQ: DDOG) were all falling today, along with many other tech stocks, as investors expect the Federal Reserve to hike interest rates when it meets later this week. Shopify was down 4.4%, Doximity had plummeted 12.8%, and Datadog had tumbled 6.8% as of 2:57 p.m. ET.
Shares of Nio (NYSE: NIO) crashed at the open Monday morning, as investors are fleeing many Chinese names, including this electric vehicle (EV) maker. The company's American depositary shares pared some of the initial 14% drop, but remained down by 2.6% as of 10:25 a.m. ET. Nio shares are getting hit from several different angles.
The company has seen its stock price plummet precipitously this year, down 41% year to date and roughly 61% since early November. It currently trades under $9 per share and was hit hard by the correction of overvalued growth stocks. For one, it is a fintech that has a bank charter, which it received in February.
Oil and gas stocks that were popping until last week opened Monday on a weak note, with some stocks in particular taking a hard hit. ExxonMobil (NYSE: XOM) was down 3.2%. Transocean (NYSE: RIG) was down 10.7%.
The S&P 500 has performed so poorly it is now trading at a scarily low level. That usually presents an opportunity for longer-term investors.
Here are five of the safest high-yield dividend stocks on the planet. The company's dividend yield currently tops 5%, which certainly puts it in the high-yield group. While there are other REITs in this space, Easterly has a secure spot among the market leaders.
Reuters reported over the weekend that the ongoing conflict in Ukraine will almost certainly disrupt supplies of neon gas, which is vital for the manufacture of semiconductor chips. On the other hand, if input costs rise for Nvidia, that would squeeze its profit margins. Adding to Nvidia's troubles, on Monday morning, Citigroup released a report warning of "incredibly bearish" sentiment regarding semiconductor stocks.
Shares of Nielsen Holdings (NYSE: NLSN) charged sharply higher on Monday, surging as much as 47.1%. The catalyst that sent the television ratings and data analytics platform higher was a rumor that the company could be taken private. Reports emerged today that a syndicate of private-equity companies are in "advanced talks" to acquire Nielsen for roughly $15 billion including debt, according to a report in The Wall Street Journal.
Monday opened lower for Nasdaq stocks once again, with the index down more than 1% — and today it appears that the fuel cell stocks are leading this market lower. As of 12:30 p.m. ET, shares of fuel cell pioneer Plug Power (NASDAQ: PLUG) are sliding 6.1%, followed by fuel-cell-powered semitruck company Nikola Corporation (NASDAQ: NKLA) with a 7.1% loss, and stationary fuel cell power specialist Bloom Energy (NYSE: BE) with a loss of 9.3%. As the company reported, despite selling more fuel cells than planned in Q4, Ballard suffered much steeper losses than anticipated — $0.15 per share, instead of the $0.06 per share loss predicted by Wall Street analysts.
Announcing a new chief operating officer today didn't stem the decline after it reported earnings last week.
Shares of Turquoise Hill Resources (NYSE: TRQ) surged 31.9% on Monday after the mining company received a takeover bid from Rio Tinto (NYSE: RIO). Rio Tinto is seeking to purchase the 49% of Turquoise Hill's stock that it doesn't already own. To do so, the mining titan offered to buy Turquoise Hill's remaining shares for roughly $2.7 billion in cash.
Oil prices remain at high levels, making these stocks potentially big winners says Goldman Sachs.

source